{"product_id":"the-eyes-isbn-9781394252688","title":"The Eyes","description":"\u003cp\u003e\u003cb\u003ePEATE’S BODY SYSTEMS\u003cbr\u003e THE EYES\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003cb\u003eA CONCISE, ILLUSTRATED, AND ACCESSIBLE GUIDE TO THE EYES\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eEach of the twelve volumes in \u003ci\u003ePeate’s Body Systems\u003c\/i\u003e series is rooted in the belief that a deep and thorough understanding of the human body is essential for providing the highest standard of care. Offering clear, accessible and up-to-date information on different body systems, this series bridges the gap between complex scientific concepts and practical, everyday applications in health and care settings. This series makes for an invaluable resource for those committed to understanding the intricacies of human biology, physiology and the various systems that sustain life. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eThe Eyes\u003c\/i\u003e is the perfect companion for students and newly registered practitioners across nursing and allied health fields with an interest in eye care, providing a comprehensive yet easy-to-digest guide for both academic and clinical application. \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eEquips healthcare students and practitioners with the necessary information to provide safe and competent care\u003c\/li\u003e\n\u003cli\u003eFeatures colourful illustrations to aid comprehension, clarify complicated concepts, and render content more engaging and accessible\u003c\/li\u003e\n\u003cli\u003eEmpowers readers to adapt to a rapidly evolving healthcare landscape, preparing them for the future of healthcare delivery\u003c\/li\u003e\n\u003cli\u003eContains information necessary for effective patient care of those with glaucoma, cataract, macular degeneration, and other eye diseases and conditions\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003ePreface ix\u003c\/p\u003e \u003cp\u003eAcknowledgements xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Anatomy and Physiology: The Eyes 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe Sense of Sight 1\u003c\/p\u003e \u003cp\u003eThe Anatomy and Physiology of the Eye 4\u003c\/p\u003e \u003cp\u003eConjunctiva 6\u003c\/p\u003e \u003cp\u003eLacrimal Apparatus 7\u003c\/p\u003e \u003cp\u003eThe Eye 8\u003c\/p\u003e \u003cp\u003eOrganisation of the Retina 10\u003c\/p\u003e \u003cp\u003eColour Vision and Retinal Structure 10\u003c\/p\u003e \u003cp\u003eEye Chambers 12\u003c\/p\u003e \u003cp\u003eFocusing Images on the Retina 12\u003c\/p\u003e \u003cp\u003eRefraction 12\u003c\/p\u003e \u003cp\u003eFocal Length 13\u003c\/p\u003e \u003cp\u003eMyopia, Hyperopia and Presbyopia 14\u003c\/p\u003e \u003cp\u003eProcessing of Visual Information 15\u003c\/p\u003e \u003cp\u003eCentral Processing of Visual Information 15\u003c\/p\u003e \u003cp\u003eConclusion 16\u003c\/p\u003e \u003cp\u003eGlossary of Terms 16\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 17\u003c\/p\u003e \u003cp\u003eReferences 19\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Assessment of the Eyes 20\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eImportance of Vision Assessment 20\u003c\/p\u003e \u003cp\u003eThe Assessment 21\u003c\/p\u003e \u003cp\u003ePatient History in Ophthalmic Assessment 24\u003c\/p\u003e \u003cp\u003eDocumentation of Findings 24\u003c\/p\u003e \u003cp\u003eTesting Visual Function 27\u003c\/p\u003e \u003cp\u003eLogMAR Vision Testing 29\u003c\/p\u003e \u003cp\u003eTumbling ‘E’, ‘E’ Test 29\u003c\/p\u003e \u003cp\u003eColour Vision Assessment 30\u003c\/p\u003e \u003cp\u003eDiagnostic Tests 31\u003c\/p\u003e \u003cp\u003eConclusion 33\u003c\/p\u003e \u003cp\u003eGlossary of Terms 34\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 35\u003c\/p\u003e \u003cp\u003eReferences 36\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Glaucoma 37\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePathophysiological Changes Associated with Primary Open-angle Glaucoma 37\u003c\/p\u003e \u003cp\u003eEpidemiology 39\u003c\/p\u003e \u003cp\u003eRisk Factors 41\u003c\/p\u003e \u003cp\u003eClinical Presentation 42\u003c\/p\u003e \u003cp\u003eClinical Investigations and Diagnosis 43\u003c\/p\u003e \u003cp\u003eManagement 44\u003c\/p\u003e \u003cp\u003eHealth Teaching 47\u003c\/p\u003e \u003cp\u003eConclusion 49\u003c\/p\u003e \u003cp\u003eGlossary of Terms 50\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 51\u003c\/p\u003e \u003cp\u003eReferences 52\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Cataract 54\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePathophysiological Changes Associated with Cataract 56\u003c\/p\u003e \u003cp\u003eEpidemiology 58\u003c\/p\u003e \u003cp\u003eRisk Factors 59\u003c\/p\u003e \u003cp\u003eClinical Presentation 59\u003c\/p\u003e \u003cp\u003eClinical Investigations and Diagnosis 61\u003c\/p\u003e \u003cp\u003eManagement 64\u003c\/p\u003e \u003cp\u003eSurgical Management 65\u003c\/p\u003e \u003cp\u003eCataract Surgery Procedure 65\u003c\/p\u003e \u003cp\u003eTypes of Intra-optical Lenses 66\u003c\/p\u003e \u003cp\u003ePostoperative Care 66\u003c\/p\u003e \u003cp\u003eHealth Teaching 66\u003c\/p\u003e \u003cp\u003eConclusion 69\u003c\/p\u003e \u003cp\u003eGlossary of Terms 70\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 71\u003c\/p\u003e \u003cp\u003eReferences 72\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Conjunctivitis 73\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePink Eye 73\u003c\/p\u003e \u003cp\u003eViral Conjunctivitis 73\u003c\/p\u003e \u003cp\u003eBacterial Conjunctivitis 73\u003c\/p\u003e \u003cp\u003eAllergic Conjunctivitis 73\u003c\/p\u003e \u003cp\u003eChemical Conjunctivitis 73\u003c\/p\u003e \u003cp\u003eGiant Papillary Conjunctivitis 74\u003c\/p\u003e \u003cp\u003eNeonatal Conjunctivitis 74\u003c\/p\u003e \u003cp\u003eNon-infectious Conjunctivitis 74\u003c\/p\u003e \u003cp\u003ePathophysiological Changes Associated with Conjunctivitis 74\u003c\/p\u003e \u003cp\u003eConjunctival Anatomy and Function 75\u003c\/p\u003e \u003cp\u003eTypes of Conjunctivitis and Specific Pathophysiological Mechanisms 76\u003c\/p\u003e \u003cp\u003eProtective Mechanisms and Self-limiting Nature 77\u003c\/p\u003e \u003cp\u003eEpidemiology 78\u003c\/p\u003e \u003cp\u003eOphthalmia Neonatorum 78\u003c\/p\u003e \u003cp\u003eRisk Factors 79\u003c\/p\u003e \u003cp\u003eGeneral Risks Across All Types 80\u003c\/p\u003e \u003cp\u003ePopulations at Higher Risk 80\u003c\/p\u003e \u003cp\u003eClinical Presentation 81\u003c\/p\u003e \u003cp\u003eClinical Investigations and Diagnosis 83\u003c\/p\u003e \u003cp\u003eManagement 87\u003c\/p\u003e \u003cp\u003eBacterial Conjunctivitis 87\u003c\/p\u003e \u003cp\u003eViral Conjunctivitis 88\u003c\/p\u003e \u003cp\u003eAllergic Conjunctivitis 88\u003c\/p\u003e \u003cp\u003eChemical Conjunctivitis 88\u003c\/p\u003e \u003cp\u003eFurther Considerations 89\u003c\/p\u003e \u003cp\u003eHealth Teaching 89\u003c\/p\u003e \u003cp\u003eConclusion 90\u003c\/p\u003e \u003cp\u003eGlossary of Terms 91\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 92\u003c\/p\u003e \u003cp\u003eReferences 93\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Age-related Macular Degeneration 94\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMacular Degeneration 94\u003c\/p\u003e \u003cp\u003ePathophysiological Changes Associated with Age-related Macular Degeneration 95\u003c\/p\u003e \u003cp\u003eDry (Non-exudative or Atrophic) 95\u003c\/p\u003e \u003cp\u003eWet (Neovascular or Exudative) Age-related Macular Degeneration 97\u003c\/p\u003e \u003cp\u003eEpidemiology 99\u003c\/p\u003e \u003cp\u003eRisk Factors 99\u003c\/p\u003e \u003cp\u003eClinical Presentation 100\u003c\/p\u003e \u003cp\u003eDry Age-related Macular Degeneration (Atrophic) 101\u003c\/p\u003e \u003cp\u003eWet Age-related Macular Degeneration (Neovascular or Exudative) 101\u003c\/p\u003e \u003cp\u003eGeneral Symptoms of Age-related Macular Degeneration 102\u003c\/p\u003e \u003cp\u003eClinical Investigations and Diagnosis 103\u003c\/p\u003e \u003cp\u003eInitial Consultation 103\u003c\/p\u003e \u003cp\u003eSymptom Inquiry 104\u003c\/p\u003e \u003cp\u003eStructured Interviews and Questionnaires 104\u003c\/p\u003e \u003cp\u003eDocumentation and Follow-up 105\u003c\/p\u003e \u003cp\u003eVisual Acuity Test 106\u003c\/p\u003e \u003cp\u003eAmsler Grid Test 106\u003c\/p\u003e \u003cp\u003eFundoscopic Examination (Ophthalmoscopy) 106\u003c\/p\u003e \u003cp\u003eOptical Coherence Tomography 106\u003c\/p\u003e \u003cp\u003eFluorescein Angiography 107\u003c\/p\u003e \u003cp\u003eIndocyanine Green Angiography 107\u003c\/p\u003e \u003cp\u003eFundus Autofluorescence 107\u003c\/p\u003e \u003cp\u003eElectroretinography 107\u003c\/p\u003e \u003cp\u003eManagement 107\u003c\/p\u003e \u003cp\u003eHealth Teaching 109\u003c\/p\u003e \u003cp\u003eConclusion 110\u003c\/p\u003e \u003cp\u003eGlossary of Terms 111\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 112\u003c\/p\u003e \u003cp\u003eReferences 113\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Retinitis 114\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eRetinal Dystrophies 114\u003c\/p\u003e \u003cp\u003eTypes 114\u003c\/p\u003e \u003cp\u003eSymptoms 115\u003c\/p\u003e \u003cp\u003eCauses 115\u003c\/p\u003e \u003cp\u003ePathophysiological Changes Associated with Retinitis Pigmentosa 116\u003c\/p\u003e \u003cp\u003eGenetic Mutations 116\u003c\/p\u003e \u003cp\u003ePhotoreceptor Degeneration 116\u003c\/p\u003e \u003cp\u003eRetinal Pigment Epithelium Changes 117\u003c\/p\u003e \u003cp\u003eVascular Changes 117\u003c\/p\u003e \u003cp\u003eRetinal Remodelling 117\u003c\/p\u003e \u003cp\u003eInflammatory Responses 117\u003c\/p\u003e \u003cp\u003eSecondary Effects 117\u003c\/p\u003e \u003cp\u003eClinical Implications 117\u003c\/p\u003e \u003cp\u003eEpidemiology 118\u003c\/p\u003e \u003cp\u003eRisk Factors 118\u003c\/p\u003e \u003cp\u003eGenetic Mutations 118\u003c\/p\u003e \u003cp\u003eEnvironmental and Lifestyle Factors 119\u003c\/p\u003e \u003cp\u003eAge of Onset 120\u003c\/p\u003e \u003cp\u003eClinical Presentation 120\u003c\/p\u003e \u003cp\u003eInitial Symptoms 120\u003c\/p\u003e \u003cp\u003eClinical Investigations and Diagnosis 122\u003c\/p\u003e \u003cp\u003ePatient History 122\u003c\/p\u003e \u003cp\u003eSymptom Onset and Progression 122\u003c\/p\u003e \u003cp\u003eCentral Vision Changes 123\u003c\/p\u003e \u003cp\u003eFamily History 123\u003c\/p\u003e \u003cp\u003ePrevious Ocular and Medical History 123\u003c\/p\u003e \u003cp\u003eVisual Function Impact 124\u003c\/p\u003e \u003cp\u003ePsychosocial Aspects 124\u003c\/p\u003e \u003cp\u003eExamination and Investigations 125\u003c\/p\u003e \u003cp\u003eClinical Examination 125\u003c\/p\u003e \u003cp\u003eRetinal Imaging 125\u003c\/p\u003e \u003cp\u003eFunctional Tests 126\u003c\/p\u003e \u003cp\u003eGenetic Testing 126\u003c\/p\u003e \u003cp\u003eAdditional Tests 126\u003c\/p\u003e \u003cp\u003eVisual Field Testing (Perimetry) 127\u003c\/p\u003e \u003cp\u003eManagement 127\u003c\/p\u003e \u003cp\u003eGene Therapy 128\u003c\/p\u003e \u003cp\u003eHealth Teaching 129\u003c\/p\u003e \u003cp\u003eConclusion 130\u003c\/p\u003e \u003cp\u003eGlossary of Terms 130\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 131\u003c\/p\u003e \u003cp\u003eReferences 132\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Presbyopia 134\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMyopia, Hyperopia and Presbyopia 134\u003c\/p\u003e \u003cp\u003eEmmetropia 134\u003c\/p\u003e \u003cp\u003eRefractive Error 134\u003c\/p\u003e \u003cp\u003ePathophysiological Changes Associated with Presbyopia 134\u003c\/p\u003e \u003cp\u003eEpidemiology 137\u003c\/p\u003e \u003cp\u003eRisk Factors 138\u003c\/p\u003e \u003cp\u003eClinical Presentation 140\u003c\/p\u003e \u003cp\u003eClinical Investigations and Diagnosis 140\u003c\/p\u003e \u003cp\u003eManagement 143\u003c\/p\u003e \u003cp\u003eHealth Teaching 143\u003c\/p\u003e \u003cp\u003eConclusion 145\u003c\/p\u003e \u003cp\u003eGlossary of Terms 146\u003c\/p\u003e \u003cp\u003eMultiple Choice Questions 147\u003c\/p\u003e \u003cp\u003eReferences 148\u003c\/p\u003e \u003cp\u003eMCQ Answers 150\u003c\/p\u003e \u003cp\u003eIndex 151\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eIAN PEATE\u003c\/b\u003e is a Visiting Professor at Northumbria University, a Senior Clinical Fellow at the University of Hertfordshire, and a Professorial Fellow at the University of Roehampton. He is also the Editor-in-Chief of the \u003ci\u003eBritish Journal of Nursing\u003c\/i\u003e and the Consultant Editor of the \u003ci\u003eJournal of Paramedic Practice\u003c\/i\u003e and the \u003ci\u003eInternational Journal of Advancing Practice\u003c\/i\u003e.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003ePEATE’S BODY SYSTEMS\u003cbr\u003e THE EYES\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003cb\u003eA CONCISE, ILLUSTRATED, AND ACCESSIBLE GUIDE TO THE EYES\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eEach of the twelve volumes in \u003ci\u003ePeate’s Body Systems\u003c\/i\u003e series is rooted in the belief that a deep and thorough understanding of the human body is essential for providing the highest standard of care. Offering clear, accessible and up-to-date information on different body systems, this series bridges the gap between complex scientific concepts and practical, everyday applications in health and care settings. This series makes for an invaluable resource for those committed to understanding the intricacies of human biology, physiology and the various systems that sustain life. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eThe Eyes\u003c\/i\u003e is the perfect companion for students and newly registered practitioners across nursing and allied health fields with an interest in eye care, providing a comprehensive yet easy-to-digest guide for both academic and clinical application. \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eEquips healthcare students and practitioners with the necessary information to provide safe and competent care\u003c\/li\u003e\n\u003cli\u003eFeatures colourful illustrations to aid comprehension, clarify complicated concepts, and render content more engaging and accessible\u003c\/li\u003e\n\u003cli\u003eEmpowers readers to adapt to a rapidly evolving healthcare landscape, preparing them for the future of healthcare delivery\u003c\/li\u003e\n\u003cli\u003eContains information necessary for effective patient care of those with glaucoma, cataract, macular degeneration, and other eye diseases and conditions\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47990226026725,"sku":"NP9781394252688","price":21.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781394252688.jpg?v=1761786980","url":"https:\/\/k12savings.com\/es\/products\/the-eyes-isbn-9781394252688","provider":"K12savings","version":"1.0","type":"link"}